11. Anesthesia and heart valve diseases

ASMARATS L, TARAMASSO M, RODÉS-CABAU J. Tricuspid valve disease: diagnosis, prognosis and management of a rapidly evolving field. Nat Rev Cardiol 2019; 16:538-54
BAX JJ, DELGADO V. Advanced imaging in valvular heart disease. Nat Rev Cardiol 2017; 14:209-23
BONOW RO. Chronic mitral regurgitation and aortic regurgitation. J Am Coll Cardiol 2013; 61:693-701
CAHILL TJ, PRENDERGAST BD. Infective endocarditis. Lancet 2016; 387:882-93
CHERRY SV, JAIN P, RODRIGUEZ-BLANCO YF, FABBRO M. Noninvasive evaluation of native valvular regurgitation: a review of the 2017 American Society of Echocardiography Guidelines for the perioperative echocardiographer. J Cardiothorac Vasc Anesth 2018; 32:811-22
GÉNÉREUX P, STONE GW, O'GARA PT, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol 2016; 67:2263-88
HENSLEY N, DIETRICH J, NYHAN D, et al. Hypertrophic cardiomyopathy: a review. Anesth Analg 2015; 120:554-69
JAIN P, FABBRO M. ACC Expert Consensus Pathway on management of mitral regurgitation: a review of the 2017 document for cardiac anesthesiologists. J Cardiothorac Vasc Anesth 2019; 33:274-89
KODALI SK, VELAGAPIDI P, HAHN RT, et al. Valvular heart disease in patients ≥ 80 years of age. J Am Coll Cardiol 2018; 71:2058-72
LEVINE RA, HAGÉGE AA, JUDGE DP, et al. Mitral valve disease – morphology and mechanisms. Nat Rev Cardiol 2015; 12:689-710
MAHMOOD F, MATYAL R. A quantitative approach to the intraoperative echocardiographic assessment of the mitral valve for repair. Anesth Analg 2015; 121:34-58
MARTIN AK, MOHANANEY D, RANKA S; et al. The 2017 European Society of Cardiology (ESC)/European Association of Cardiothoracic Surgeons (EACTS) Guidelines for management of valvular heart disease – Highlights and perioperative implications. J Cardiothorac Vasc Anesth 2018; 32:2810-6
MASLOW A. Mitral valve repair: an echocardiographic review: Part I. J Cardiothorac Vasc Anesth 2015; 29:156-77
MASLOW A. Mitral valve repair: an echocardiographic review: Part II. J Cardiothorac Vasc Anesth 2015; 29:439-71
PIBAROT P, DUMESNIL JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 2009; 119:1034-48
PRODROMO J, D'ANCONNA G, AMADUCCI A, et al. Aortic valve repair fort aortic insufficiency: a review. J Cardiothorac Vasc Anesth 2012; 26:923-32
SAIKRISHNAN N, KUMAR G, SAWAYA FJ, et al. Accurate assessment of aortic stenosis: a review of diagnostic modalities and hemodynamics. Circulation 2014; 129:244-53
SHAKIL O, JAINANDUNSING JS, ILIC R, et al. Ischemic mitral regurgitation: an intraoperative echocardiographic perspective. J Cardiothorac Vasc Anesth 2013; 27:573-85
UNGER P, CLAVEL MA, LINDMAN BR, et al. Pathophysiology and management of multivalvular disease. Nat Rev Cardiol 2016; 13:429-40

Recommandations

BAUMGARTNER H, FALK V, BAX JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38:2739-91 (voir Directives: Valvulopathies ESC 2017.pdf)
BONOW RO, BROWN AS, GILLAM LD, et al. ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS/ 2017 appropriate use criteria for the treatment of patients with severe aortic stenosis. J Am Coll Cardiol 2017; 70:2566-98 (voir Directives: Stén aortique 2017.pdf)
DE BONIS M, AL-ATTAR N, ANTUNES M, et al. Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology working groups on Cardiovascular Surgery and Valvular Heart Disease. Eur Heart J 2016; 37:133-9 (voir Directives: IM chirurgie ESC.pdf)
HABIB G, LANCELLOTTI P, ANTUNES MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J 2015; 36:3075-123 (voir Directives: Endocardite ESC.pdf)
NISHIMURA RA, OTTO CM, BONOW RO, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease. Circulation 2014; 129:e521-e643 (voir Directives: Valvulopath AHA ACC 2014.pdf)
NISHIMURA RA, OTTO CM, BONOW RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease. J Am Coll Cardiol 2017; 70:252-89 (voir Directives: Valvulopath AHA update 2017.pdf)
O'GARA PT, GRAYBURN PA, BADHWAR V, et al. 2017 ACC Expert consensus décision pathway on the management of mitral regurgitation. J Am Coll Cardiol 2017; 70:2421-49 (voir Directives: IM ACC 2017.pdf)
SINGH M, SPORN ZA, SCHAFF HV, PELLIKKA PA. ACC/AHA versus ESC Guidelines on prosthetic heart valve management. J Am Coll Cardiol 2019; 73:1707-18 (voir Directives: Prothèses ACC AHA 2019.pdf)
VAHANIAN A, ALFIERI O, ANDREOTTI F, et al. Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012; 33:2451-96 (voir Directives: Valvulopathies ESC 2012.pdf)
ZOGHBI WA, ADAMS D, BONOW RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the ASE developed in collaboration with the SCMR. J Am Soc Echocardiogr 2017; 30:303-71 (voir Diret Echo Insuff valv 2017.pdf)
ZOGHBI WA, CHAMBERS JB, DUMESNIL JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography andDoppler ultrasound. J Am Soc Echocradiogr 2009; 22:975-1014 (voir Diretectives Echo prothèses 2009.pdf)

PDF version of "Recommandations" can be downloaded from : Téléchargement / Directives CCV:
Valvulopathies.

Table 11.6 and 11.7 sum up patient management in case of stenosis or insufficiency.